Sionov Ronit Vogt, Fridlender Zvi G, Granot Zvi
Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel Canada, Hebrew University Medical School, 91120, Jerusalem, Israel.
Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, 96920, Jerusalem, Israel.
Cancer Microenviron. 2015 Dec;8(3):125-58. doi: 10.1007/s12307-014-0147-5. Epub 2014 Jun 4.
Neutrophils are myeloid cells that constitute 50-70 % of all white blood cells in the human circulation. Traditionally, neutrophils are viewed as the first line of defense against infections and as a major component of the inflammatory process. In addition, accumulating evidence suggest that neutrophils may also play a key role in multiple aspects of cancer biology. The possible involvement of neutrophils in cancer prevention and promotion was already suggested more than half a century ago, however, despite being the major component of the immune system, their contribution has often been overshadowed by other immune components such as lymphocytes and macrophages. Neutrophils seem to have conflicting functions in cancer and can be classified into anti-tumor (N1) and pro-tumor (N2) sub-populations. The aim of this review is to discuss the varying nature of neutrophil function in the cancer microenvironment with a specific emphasis on the mechanisms that regulate neutrophil mobilization, recruitment and activation.
中性粒细胞是髓系细胞,占人体循环中所有白细胞的50-70%。传统上,中性粒细胞被视为抵御感染的第一道防线,也是炎症过程的主要组成部分。此外,越来越多的证据表明,中性粒细胞可能在癌症生物学的多个方面也发挥关键作用。半个多世纪前就有人提出中性粒细胞可能参与癌症的预防和促进,然而,尽管中性粒细胞是免疫系统的主要组成部分,但其作用常常被淋巴细胞和巨噬细胞等其他免疫成分所掩盖。中性粒细胞在癌症中似乎具有相互矛盾的功能,可分为抗肿瘤(N1)和促肿瘤(N2)亚群。本综述的目的是讨论癌症微环境中中性粒细胞功能的不同性质,特别强调调节中性粒细胞动员、募集和激活的机制。